Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

CTIX Upcoming Presentations: 1. The 23rd Annual

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
Posted On: 08/28/2016 10:48:59 PM
Avatar
Posted By: sox0407
CTIX Upcoming Presentations:

1. The 23rd Annual Newsmakers in the Biotech Industry

Friday, September 9, 9-9:30 AM

http://www.biocentury.com/data/newscenter2/co...hedule.pdf

2. Prurisol, a New Small Molecule to Treat Psoriasis, Completed Phase 2 Trial and now Geared up for Phase 3

• Strategy and science behind breakthrough oral small molecule, which is an immune-modulator affecting IL-20 and PRINS
• Lessons from discovery and early development, opening up a new pathway to treat psoriasis
• Obtaining a 505B(2) pathway; Key challenges and lessons on how this innovative small molecule was developed

Monday, September 19, 9:30 AM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

3. Understanding Mechanisms, Novel Targets and Pathways to Further Novel Therapeutic Development in Dermatology

Monday, September 19, 10:05 AM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

4. Utilizing New Tech for Med Derm Research and Development

• Biomarkers, Diagnostics, Imaging
• Target Engagement
• Skin Pharmacokinetics (PK)

Monday, September 19, 12:55 PM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

5. Understanding Key Challenges and Special Considerations of Dermatology Drug Development

Monday, September 19, 2:10 PM

Krishna Menon, Ph.D., President and Chief Scientific Officer, Cellceutix Corporation

http://www.discoveryontarget.com/uploadedFile...ochure.pdf


(6)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Dont-give-up.jpg




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us